C-Lab Ltd (CLAB.TA)
ILA 1215.0
(-0.25%)
ILA 1215.0
(-0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 594 Thousand | 11.58 Million | -4.84 Million | 20.69 Million | 614.4 Million | 9.64 Million |
| Net Income | 20.51 Million | 6.98 Million | 1.17 Million | 11.45 Million | 546 Million | 5.38 Million |
| Depreciation & Amortization | 2.98 Million | 2.13 Million | 3 Million | 3.82 Million | 454.2 Million | 6.8 Million |
| Deferred income taxes | - | -76 Thousand | 454 Thousand | -144 Thousand | - | 360.84 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 9.93 Million | 2.36 Million | -8.79 Million | 4.58 Million | -293.1 Million | -2.31 Million |
| Other non-cash items | -32.84 Million | 13.44 Million | 25.63 Million | 5.62 Million | -92.7 Million | 10.61 Million |
| Investing Cash Flow | -1.41 Million | -241 Thousand | 2.17 Million | -194 Thousand | -562.1 Million | -3.74 Million |
| Investments in PPE | -1.41 Million | -241 Thousand | -1.29 Million | -976 Thousand | -562.1 Million | -4.04 Million |
| Acquisitions | - | - | - | 782 Thousand | - | 307.1 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 3.47 Million | - | - | - |
| Financing Cash Flow | 697 Thousand | - | -4.8 Million | -6 Million | -180.9 Million | -5.57 Million |
| Debt repayment | - | - | -4.8 Million | -6 Million | -300.9 Million | -5.19 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -1.08 Billion | 120 Million | -376.19 Thousand |
| Accounts receivables | 782 Thousand | 2.7 Million | -3.25 Million | 6.18 Million | -115.6 Million | -2.58 Million |
| Accounts payables | - | 1.8 Million | 3.03 Million | -2.06 Million | - | -2.6 Million |
| Inventory | 9.15 Million | -13.49 Million | -20.09 Million | -1.13 Million | -407.8 Million | 7.61 Million |
| Other working capital | -199.8 Million | 11.34 Million | 11.51 Million | 1.59 Million | 230.3 Million | -4.73 Million |
| Cash at beginning of period | 21.3 Million | 7.75 Million | 15.8 Million | 2.37 Million | 309.1 Million | 2.07 Million |
| Cash at end of period | 21.45 Million | 21.3 Million | 7.75 Million | 15.8 Million | 150.1 Million | 2.37 Million |
| Capital Expenditure | -1.41 Million | -241 Thousand | -1.29 Million | -976 Thousand | -562.1 Million | -4.04 Million |
| Effect of forex changes on cash | 270 Thousand | 220.6 Million | -578 Thousand | -1.08 Million | -30.4 Million | - |
| Net cash flow / Change in cash | 148 Thousand | 13.55 Million | -8.04 Million | 13.42 Million | -159 Million | 308.42 Thousand |
| Free Cash Flow | -819 Thousand | 11.34 Million | -6.14 Million | 19.72 Million | 52.3 Million | 5.59 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.5 Million | 9.5 Million | 20.51 Million | 13.63 Million | 768.95 Million | 8.4 Million |
| Depreciation & Amortization | 74.15 Million | 74.15 Million | 2.98 Million | 1.57 Million | 78.7 Million | 1.41 Million |
| Deferred income taxes | -29 Thousand | - | - | - | - | -243 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 621.7 Million | 621.7 Million | 9.93 Million | 13.6 Million | 658.3 Million | -3.67 Million |
| Other non-cash items | -232.75 Million | -232.75 Million | -32.84 Million | -22.4 Million | -1.18 Billion | -11.96 Million |
| Investing Cash Flow | -9.9 Million | -9.9 Million | -1.41 Million | -518 Thousand | -12.4 Million | -895 Thousand |
| Investments in PPE | -9.9 Million | -9.9 Million | -1.41 Million | -518 Thousand | -12.4 Million | -895 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 697 Thousand | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 84.1 Million | 84.1 Million | 782 Thousand | 3.05 Million | 152.85 Million | -2.27 Million |
| Accounts payables | 2.17 Million | - | - | - | - | -1.18 Million |
| Inventory | 413.05 Million | 413.05 Million | 9.15 Million | 10.55 Million | 527.7 Million | -1.4 Million |
| Other working capital | 124.55 Million | 124.55 Million | -199.8 Million | -2000.00 | -22.25 Million | -3.81 Million |
| Cash at beginning of period | 15.56 Million | - | 21.3 Million | 21.3 Million | - | 21.3 Million |
| Cash at end of period | 31.92 Million | 523.7 Million | 21.45 Million | 27.2 Million | 294.45 Million | 14.58 Million |
| Capital Expenditure | -9.9 Million | -9.9 Million | -1.41 Million | -518 Thousand | -12.4 Million | -895 Thousand |
| Effect of forex changes on cash | 61 Million | 61 Million | 270 Thousand | -14.35 Million | -14.35 Million | 49.2 Million |
| Net cash flow / Change in cash | 16.36 Million | 523.7 Million | 148 Thousand | 5.89 Million | 294.45 Million | -6.72 Million |
| Free Cash Flow | 462.7 Million | 462.7 Million | -819 Thousand | 5.89 Million | 308.8 Million | -6.72 Million |
241590
ALNXT
HEBA-B
MCHN
PPM
SPEC